RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

Thanks for the post outlining the management stock options. I agree with you that the lack of low priced options would be yet another reason why a dilutive financing, and an ADHD trial will be the choice of management irregardless of the terms or what they will have to give away in return for a fully funded trial.
My guess is that until they have a completed trial under their belt, both their stock options and job prospects in the current pharma climate will be limited.
As mentioned in my last post, I believe they will issue SA as a lovin' spoonful of sugar to help the unpleasant taste of dilutive medicine go down.
Do you believe in magic?
Evidently I do, since despite the freight train of dilution comming down the track, I'm not selling a share until I see what the SA Santa brings, and what the Grinch wants to fund our ADHD study.